Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company offers pathology and radiology testing; lab staff training; technical; and lab management services. As of March 31, 2020, the company had 216 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 3,095 patient service centers and 6,995 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India. The ISIN of this stock is INE600L01024.